<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>40(1)</volume><submitter>Babar Z</submitter><pubmed_abstract>The outbreak of the recent coronavirus (SARS-CoV-2), which causes a severe pneumonia infection, first identified in Wuhan, China, imposes significant risks to public health. Around the world, researchers are continuously trying to identify small molecule inhibitors or vaccine candidates by targeting different drug targets. The SARs-CoV-2 macrodomain-I, which helps in viral replication and hijacking the host immune system, is also a potential drug target. Hence, this study targeted viral macrodomain-I by using drug similarity, virtual screening, docking and re-docking approaches. A total of 64,043 compounds were screened, and potential hits were identified based on the docking score and interactions with the key residues. The top six hits were subjected to molecular dynamics simulation and </pubmed_abstract><journal>Journal of biomolecular structure &amp; dynamics</journal><pagination>523-537</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7544951</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Drug similarity and structure-based screening of medicinal compounds to target macrodomain-I from SARS-CoV-2 to rescue the host immune system: a molecular dynamics study.</pubmed_title><pmcid>PMC7544951</pmcid><pubmed_authors>Hashmi HF</pubmed_authors><pubmed_authors>Shah A</pubmed_authors><pubmed_authors>Khan M</pubmed_authors><pubmed_authors>Noor K</pubmed_authors><pubmed_authors>Ali S</pubmed_authors><pubmed_authors>Zahra M</pubmed_authors><pubmed_authors>Babar Z</pubmed_authors><pubmed_authors>Anwar M</pubmed_authors><pubmed_authors>Suleman M</pubmed_authors><pubmed_authors>Waseem M</pubmed_authors><pubmed_authors>Ali SS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Drug similarity and structure-based screening of medicinal compounds to target macrodomain-I from SARS-CoV-2 to rescue the host immune system: a molecular dynamics study.</name><description>The outbreak of the recent coronavirus (SARS-CoV-2), which causes a severe pneumonia infection, first identified in Wuhan, China, imposes significant risks to public health. Around the world, researchers are continuously trying to identify small molecule inhibitors or vaccine candidates by targeting different drug targets. The SARs-CoV-2 macrodomain-I, which helps in viral replication and hijacking the host immune system, is also a potential drug target. Hence, this study targeted viral macrodomain-I by using drug similarity, virtual screening, docking and re-docking approaches. A total of 64,043 compounds were screened, and potential hits were identified based on the docking score and interactions with the key residues. The top six hits were subjected to molecular dynamics simulation and </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2026-05-04T19:27:43.499Z</modification><creation>2020-10-29T10:58:11Z</creation></dates><accession>S-EPMC7544951</accession><cross_references><pubmed>32897173</pubmed><doi>10.1080/07391102.2020.1815583</doi></cross_references></HashMap>